Autres langues Sumitomo Pharma Co., Ltd.

Actions

4506

JP3495000006

Temps Différé Japan Exchange Autres places de cotation 08:00:00 26/04/2024			Varia. 5j.	Varia. 1 janv.
410 ^JPY	+2,50%		-1,20%	-12,02%

29/04	Poxel : reporte la publication de ses résultats annuels 2023	AO
22/04	L'accalmie des tensions géopolitiques stimule les marchés boursiers asiatiques	MT

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Lull in Geopolitical Tensions Lifts Asian Stock Markets	22/04
Roivant Sciences Says Study of Potential Uveitis Treatment Meets Endpoints; Launches Stock Repurchase; Shares Rise	02/04
Roivant's anti-inflammatory drug succeeds in mid-stage study	02/04
Sumitomo Pharma Amends Collaboration Agreement with Otsuka Pharmaceutical	18/03
Sumitomo Pharma Co., Ltd.(TSE:4506) dropped from S&P Japan 500	18/03
Sumitomo Pharma : Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka	15/03
Sumitomo Pharma Enters into an Agreement to Amend the Worldwide Collaboration and License Agreement for Four Psychiatry and Neurology Compounds Including Ulotaront with Otsuka	15/03
Sumitomo Pharma Announces Availability of ORGOVYX in Canada, the First and Only Oral Androgen Deprivation Therapy Treatment for Men with Advanced Prostate Cancer	13/03
US Inflation Report Lifts Asian Stock Markets	01/03
Otsuka Holdings' Attributable Profit Down 9.2% 2023 On Impairment Losses	16/02
Japan's Nikkei slips after Fed chair signals delay in rate cut	01/02
Sumitomo Pharma Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024	31/01
Sumitomo Pharma Co., Ltd. Revises Consolidated Earnings Guidance for the Year Ending March 31, 2024	31/01
Fed, China Property Outlooks Roil Asian Stock Markets	30/01
Poxel Announces its Financial Calendar for 2024	04/01
Japan's Nikkei rounds off 2023 with biggest yearly gain in a decade	29/12
Sumitomo Pharma : Start of Investigator-Initiated Clinical Study of iPS Cell-Derived Dopaminergic Progenitor Cells for Parkinson’s Disease in the United States	26/12
Poxel Provides Corporate Update	22/12
Interest Rates, China Housing Measures Lift Asian Stock Markets	15/12
Sumitomo Pharma Presents Encouraging New Data on DSP-5336 Clinical Activity at the American Society of Hematology Annual Meeting	12/12

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Sumitomo Pharma Co., Ltd.

Actions

4506

JP3495000006

Autres langues

Filtres